×

Antisense modulation of apolipoprotein B-expression

  • US RE44,760 E1
  • Filed: 09/27/2012
  • Issued: 02/11/2014
  • Est. Priority Date: 11/13/2002
  • Status: Expired due to Fees
First Claim
Patent Images

1. An antisense compound 12 to 30 nucleobases in length, wherein said antisense compound is fully complementary within the range of nucleotides 5562-5625 of SEQ ID NO:

  • 3, and comprises at least one modified sugar moiety.

View all claims
  • 6 Assignments
Timeline View
Assignment View
    ×
    ×